Literature DB >> 6415735

Efficacy of clonidine in treatment of alcohol withdrawal state.

A J Wilkins, W J Jenkins, J A Steiner.   

Abstract

Clonidine hydrochloride 5 micrograms/kg and placebo were given orally to 11 patients experiencing well-developed alcohol withdrawal states. Active drug and placebo were given in a randomised, cross-over double blind fashion 2 h apart. Clonidine significantly suppressed heart rate (P = 0.002), arterial blood pressure (P = 0.006), and an accumulated score of withdrawal symptoms and signs (P = 0.004). These data suggest that clonidine may be useful in the management of alcohol withdrawal states, and that the underlying pathophysiology of at least some of these manifestations may be sympathetic nervous system hyperactivity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415735     DOI: 10.1007/BF00439278

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Effects of clonidine on morphine withdrawal signs in the rat.

Authors:  L F Tseng; H H Loh; E T Wei
Journal:  Eur J Pharmacol       Date:  1975-01       Impact factor: 4.432

2.  Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine.

Authors:  G K Aghajanian
Journal:  Nature       Date:  1978-11-09       Impact factor: 49.962

3.  Depression by clonidine of shaking behaviour elicited by nalorphine in morphine-dependent rats.

Authors:  J Vetulani; B Bednarczyk
Journal:  J Pharm Pharmacol       Date:  1977-09       Impact factor: 3.765

4.  Outpatient detoxification of heroin addiction, 1969--1973 (methadone, darvon, codeine, clonidine).

Authors:  R T Rappolt; F Lawrence
Journal:  Clin Toxicol       Date:  1979       Impact factor: 4.467

5.  Alterations in neurotransmitter function during the development of ethanol tolerance and dependence.

Authors:  B Tabakoff; C Melchior; S Urwyler; P L Hoffman
Journal:  Acta Psychiatr Scand Suppl       Date:  1980

6.  Drug tolerance in biomembranes: a spin label study of the effects of ethanol.

Authors:  J H Chin; D B Goldstein
Journal:  Science       Date:  1977-05-06       Impact factor: 47.728

7.  Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers.

Authors:  S Borg; H Kvande; G Sedvall
Journal:  Science       Date:  1981-09-04       Impact factor: 47.728

8.  Spinal sympathetic neurons: possible sites of opiate-withdrawal suppression by clonidine.

Authors:  D N Franz; D B Hare; K L McCloskey
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

9.  Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs.

Authors:  R Freedman; D Kirch; J Bell; L E Adler; M Pecevich; E Pachtman; P Denver
Journal:  Acta Psychiatr Scand       Date:  1982-01       Impact factor: 6.392

10.  Clonidine blocks acute opiate-withdrawal symptoms.

Authors:  M S Gold; D E Redmond; H D Kleber
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

View more
  14 in total

1.  Current approaches to the recognition and treatment of alcohol withdrawal and delirium tremens: "old wine in new bottles" or "new wine in old bottles".

Authors:  Theodore A Stern; Anne F Gross; Thomas W Stern; Shamim H Nejad; Jose R Maldonado
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Effect of clonidine on ultrasonic vocalization in preweaning rats.

Authors:  E Hård; J Engel; A S Lindh
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

Review 3.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

4.  The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse.

Authors:  B Costall; M E Kelly; E S Onaivi; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

5.  Pharmacology of saccadic eye movements in man. 2. Effects of the alpha 2-adrenoceptor ligands idazoxan and clonidine.

Authors:  P Glue; E White; S Wilson; D M Ball; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 6.  Acute ethanol poisoning and the ethanol withdrawal syndrome.

Authors:  B Adinoff; G H Bone; M Linnoila
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

Review 7.  Managing alcohol withdrawal in the elderly.

Authors:  K L Kraemer; J Conigliaro; R Saitz
Journal:  Drugs Aging       Date:  1999-06       Impact factor: 3.923

8.  Studies with alpha 2-adrenoceptor agonists and alcohol abstinence syndrome in rats.

Authors:  M P Parale; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

9.  The pharmacokinetics of clonidine in high dosage.

Authors:  J Fauler; L Verner
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions.

Authors:  Kimberly A Ludtke; Kevin S Stanley; Natalie L Yount; Richard D Gerkin
Journal:  Hosp Pharm       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.